The store will not work correctly when cookies are disabled.
5-[5-(Azidomethyl)-1,3,4-oxadiazol-2-yl]-2-benzylthio-4-chlorobenzenesulfonamide
ID: ALA4097363
PubChem CID: 137658709
Max Phase: Preclinical
Molecular Formula: C16H13ClN6O3S2
Molecular Weight: 436.91
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: [N-]=[N+]=NCc1nnc(-c2cc(S(N)(=O)=O)c(SCc3ccccc3)cc2Cl)o1
Standard InChI: InChI=1S/C16H13ClN6O3S2/c17-12-7-13(27-9-10-4-2-1-3-5-10)14(28(19,24)25)6-11(12)16-22-21-15(26-16)8-20-23-18/h1-7H,8-9H2,(H2,19,24,25)
Standard InChI Key: FOTBPGKLEHRJPM-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
8.9602 -6.0134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5557 -5.3076 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.1468 -6.0108 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4329 -4.0818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4318 -4.9013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1398 -5.3103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8495 -4.9009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8467 -4.0782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1380 -3.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7251 -3.6734 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.5528 -3.6669 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5497 -2.8497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2559 -2.4385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9604 -2.8479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6661 -2.4374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6635 -1.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9492 -1.2136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2465 -1.6265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7265 -5.3126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9802 -4.9797 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4329 -5.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8409 -6.2946 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6404 -6.1252 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6202 -5.5005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2884 -4.7537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2649 -4.8986 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4758 -4.6676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6344 -4.5753 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
8 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 2 0
5 19 1 0
21 24 1 0
24 25 1 0
7 2 1 0
2 26 1 0
25 27 2 0
27 28 2 0
M CHG 2 27 1 28 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 436.91 | Molecular Weight (Monoisotopic): 436.0179 | AlogP: 4.14 | #Rotatable Bonds: 7 |
Polar Surface Area: 147.84 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.11 | CX Basic pKa: ┄ | CX LogP: 2.56 | CX LogD: 2.44 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.25 | Np Likeness Score: -1.63 |
References
1. Sławiński J, Szafrański K, Pogorzelska A, Żołnowska B, Kawiak A, Macur K, Belka M, Bączek T.. (2017) Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability., 132 [PMID:28364658] [10.1016/j.ejmech.2017.03.039] |